Detalhe da pesquisa
1.
Early improvements in signs and symptoms predict clinical response to baricitinib in patients with moderate-to-severe atopic dermatitis.
Clin Exp Dermatol
; 48(8): 881-888, 2023 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37032446
2.
Sustained Resolution of Nail Psoriasis Through 5 Years with Ixekizumab: A Post-Hoc analysis from UNCOVER-3.
Acta Derm Venereol
; 102: adv00787, 2022 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36121210
3.
Time to Loss of Response following Withdrawal of Ixekizumab in Patients with Moderate-to-Severe Psoriasis.
Acta Derm Venereol
; 102: adv00672, 2022 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35170742
4.
Comparative effectiveness of biologics in clinical practice: week 12 primary outcomes from an international observational psoriasis study of health outcomes (PSoHO).
J Eur Acad Dermatol Venereol
; 36(11): 2087-2100, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35766124
5.
Subgroup Analyses by European Country-Specific Reimbursement Requirements Confirm Efficacy for Ixekizumab in Psoriasis.
J Drugs Dermatol
; 21(6): 659-667, 2022 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35674763
6.
Clinical improvement in psoriasis with specific targeting of interleukin-23.
Nature
; 521(7551): 222-6, 2015 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-25754330
7.
Patients' Illness Perception as a Tool to Improve Individual Disease Management in Primary Cutaneous Lymphomas.
Acta Derm Venereol
; 98(2): 240-245, 2018 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29048099
8.
Survival and Effectiveness of Tumour Necrosis Factor-alpha Inhibitors in the Treatment of Plaque Psoriasis under Daily Life Conditions: Report from the Psoriasis Registry Austria.
Acta Derm Venereol
; 96(2): 207-12, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26271044
9.
Integrated safety analysis: Frequency of urinary tract infections in patients with psoriasis treated with ixekizumab.
J Am Acad Dermatol
; 83(1): 261-263, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32092375
10.
No reactivation of tuberculosis in patients with latent tuberculosis infection receiving ixekizumab: A report from 16 clinical studies of patients with psoriasis or psoriatic arthritis.
J Am Acad Dermatol
; 83(5): 1436-1439, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32526319
11.
Baseline Characteristics and mNAPSI Change from Baseline Scores Through Month 12 for Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Nail Psoriasis Treated with Biologics from PSoHO.
Dermatol Ther (Heidelb)
; 14(5): 1327-1335, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38649673
12.
Live-streaming Activity and Relaxation Breaks: a (Home-)Office-Compatible Approach to Promote Break Recovery, Mood, and Attention?
Occup Health Sci
; : 1-25, 2023 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36686037
13.
Measuring Situational Cognitive Performance in the Wild: A Psychometric Evaluation of Three Brief Smartphone-Based Test Procedures.
Assessment
; : 10731911231213845, 2023 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38097924
14.
Factors Predicting Quality of Life Impairment in Adult Patients with Atopic Dermatitis: Results from a Patient Survey and Machine Learning Analysis.
Dermatol Ther (Heidelb)
; 13(4): 981-995, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36862306
15.
Comparative effectiveness of biologics for patients with moderate-to-severe psoriasis and special area involvement: week 12 results from the observational Psoriasis Study of Health Outcomes (PSoHO).
Front Med (Lausanne)
; 10: 1185523, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37457564
16.
Baricitinib provides rapid and sustained improvements in absolute EASI and SCORAD outcomes in adults with moderate-to-severe atopic dermatitis.
J Dermatolog Treat
; 34(1): 2216322, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37345379
17.
Integrated Safety Analysis on Skin Cancers among Patients with Psoriasis Receiving Ixekizumab in Clinical Trials.
Dermatol Ther (Heidelb)
; 13(8): 1773-1787, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37351831
18.
Treatment satisfaction of adult patients with moderate-to-severe atopic dermatitis treated with baricitinib in France, Germany, and the United Kingdom: results from a cross-sectional international patient survey.
J Dermatolog Treat
; 34(1): 2276047, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37965779
19.
Comparative Effectiveness of Biologics Across Subgroups of Patients with Moderate-to-Severe Plaque Psoriasis: Results at Week 12 from the PSoHO Study in a Real-World Setting.
Adv Ther
; 40(3): 869-886, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36515803
20.
Application of an Interactive Diagnosis Ranking Algorithm in a Simulated Vignette-based Environment for General Dermatology.
Dermatol Pract Concept
; 12(3): e2022117, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36159116